2.—(1) The following amendments are made to Part 1 of Schedule 1 to the Misuse of Drugs (Designation) Order (Northern Ireland) 2001(1) (which specifies Controlled Drugs to which section 7(4) of the Misuse of Drugs Act 1971 applies).
(2) In paragraph 1(a) —
(a)after “Bromazolam (8-bromo-1-methyl-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine)” insert “Brorphine”;
(b)after “1,4-Butanediol” insert “Butonitazene”;
(c)after “Clonazolam (6-(2-Chlorophenyl)-1-methyl-8-nitro-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Clonitazene”;
(d)after “Concentrate of poppy-straw” insert “Cumyl-PeGaClone”;
(e)after “Diclazepam (7-Chloro-5-(2-chlorophenyl)-1-methyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one)” insert—
“Diphenidine
Ephenidine
Ethyleneoxynitazene”;
(f)after “Etizolam” insert—
“Etodesnitazene (etazene)
Etonitazene”;
(g)after “Flubromazolam (8-Bromo-6-(2-fluorophenyl)-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4] benzodiazepine)” insert “Flunitazene”;
(h)after “Isopropylphenidate (IPP or IPPD)” insert “Isotonitazene”;
(i)after “Methcathinone” insert “Methoxyphenidine”;
(j)after “Metizolam (4-(2-Chlorophenyl)-2-ethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4] diazepine)” insert—
“Metodesnitazene (metazene)
Metonitazene”;
(k)after “Propylphenidate” insert “Protonitazene”;
(l)after “1-Cyclohexyl-4-(1,2-diphenylethyl)piperazine (MT-45)” insert—
“N-Desethyl etonitazene
N-Desethylisotonitazene
N-Desethyl protonitazene”;
(m)after “4-Methyl-5-(4-methylphenyl)-4,5-dihydrooxazol-2-amine (4,4’-DMAR)” insert—
“N-Piperidinyl-etonitazene (etonitazepipne)
N-Pyrrolidino-etonitazene (etoniazepyne)
N-Pyrrolidino protonitazene”.
Commencement Information
I1Art. 2 in operation at 27.3.2024, see art. 1(1)
S.R. 2001 No. 431, relevant amending Orders are S.R. 2019 No. 207, S.R. 2018 Nos. 174 and 3, S.R. 2015 Nos. 228 and 54, S.R. 2014 Nos. 262, 159 and 20, S.R. 2013 No. 77, S.R. 2012 No. 212, S.R. 2011 No. 154, S.R. 2010 Nos. 246 and 149, S.R. 2009 No. 389, S.R. 2005 No. 359 and S.R. 2021 No. 231.